NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pharma in Silica

Pharma in Silica

Private
CanadaHealthcare & Life Scienceshttps://pharma-insilica.com/

Last Round

Seed

May 25, 2026

Total Funding Raised

$4.42M

Company Overview

Pharma in Silica is a pharmaceutical company that develops proprietary silica nanocarrier technology to create precise, well-tolerated chemotherapy treatments for solid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug delivery platformsilica nanocarriernanomedicinetargeted cancer therapycytotoxic drug deliverynon-small cell lung cancerNSCLCpreclinical study servicesIND-enabling studiescontrolled-release technologybiotech licensingdrug formulationCMC developmentsmart drug delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharma in Silica Comparables

Compare Pharma in Silica with similar companies based on industry and business-model similarity.

Pharma in Silica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Westwood Bioscience
83%
NanOlogy, LLC
79%
DelSiTech
73%

Pharma in Silica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 25, 2026
SeedOct 30, 2024
SeedMay 2, 2023

Pharma in Silica Investors

Notable investors and investment history

Pharma in Silica investors
InvestorRounds
Investissement QuébecSeed
Keiretsu Forum CanadaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 15, 2025

    Monthly visitors increased 36% MoM.

  • Oct 30, 2024

    Raised $3M with Investissement Québec participating.

Pharma in Silica Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pharma in Silica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pharma in Silica's valuation, stock price, and market status.

Firmographic Details

HeadquartersCanada
Employee Range6
Year Founded2018
Last FundingMay 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.